NASDAQ:KURA | Free Cash Flow | Kura Oncology, Inc.

Free cash flow is operating cash flow less capital expenditure. FCF / net income requires positive matching-period earnings.

Available history
2010-12-31 to 2026-03-31
Data captured

Historical Free Cash Flow

DateOperating cash flowCapital expenditureFree cash flowFCF / net income
2026-03-31-$85.85M$128,000.00-$85.98M
2025-12-31$117.27M$2.32M$114.95M
2025-03-31-$71.93M$292,000.00-$72.22M
2024-12-31$269.13M$372,000.00$268.76M
2024-03-31-$48.84M$84,000.00-$48.93M
2023-12-31-$34.31M$16,000.00-$34.32M
2023-03-31-$35.87M$36,000.00-$35.91M
2022-12-31-$26.53M$12,000.00-$26.54M
2022-03-31-$32.18M$49,000.00-$32.23M
2021-12-31-$23.37M$102,000.00-$23.47M
2021-03-31-$28.52M$31,000.00-$28.55M
2020-12-31-$18.31M$275,000.00-$18.58M
2020-03-31-$19.82M$511,000.00-$20.33M
2019-12-31-$13.93M
2019-03-31-$14.25M
2018-12-31-$10.21M
2018-03-31-$12.85M
2017-12-31-$7.47M
2017-03-31-$8.62M
2016-12-31-$6.74M
2016-03-31-$7.31M
2015-12-31-$5.61M$15,000.00-$5.62M
2015-03-31-$4.12M$10,000.00-$4.13M
2014-12-31-$12,604.00
2014-03-31-$400.00
2013-12-31-$4,012.00
2013-03-31-$1,901.00
2012-12-31-$784.00
2012-03-31-$5,477.00
2011-12-31-$1,935.00
2011-03-31-$2,264.00
2010-12-31-$356.00

Annual Free Cash Flow

DateOperating cash flowCapital expenditureFree cash flowFCF / net income
2025-12-31-$64.06M$6.64M-$70.7M
2024-12-31$134.32M$472,000.00$133.85M
2023-12-31-$124.82M$168,000.00-$124.99M
2022-12-31-$110.06M$626,000.00-$110.69M
2021-12-31-$104.55M$1.15M-$105.7M
2020-12-31-$69.83M$2.17M-$72M
2019-12-31-$54.76M
2018-12-31-$48.66M
2017-12-31-$28.44M
2016-12-31-$25.35M
2015-12-31-$17.93M$64,000.00-$17.99M
2014-12-31-$15,955.00
2013-12-31-$23,234.00
2012-12-31-$24,418.00
2011-12-31-$22,678.00
2010-12-31-$19,244.00